• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group.

作者信息

Plouin P F, Chatellier G, Darné B, Raynaud A

机构信息

Hypertension Department, Hôpital Broussais, and INSERM U-36, Paris, France.

出版信息

Hypertension. 1998 Mar;31(3):823-9. doi: 10.1161/01.hyp.31.3.823.

DOI:10.1161/01.hyp.31.3.823
PMID:9495267
Abstract

Data for the effects on blood pressure of renal artery balloon angioplasty are mostly from uncontrolled studies. The aim of this study was to document the efficacy and safety of angioplasty for lowering blood pressure in patients with atherosclerotic renal artery stenosis. Patients were randomly assigned antihypertensive drug treatment (control group, n = 26) or angioplasty (n = 23). Twenty-four-hour ambulatory blood pressure, the primary end point, was measured at baseline and at termination. Termination took place 6 months after randomization or earlier in patients who developed refractory hypertension. In those allocated angioplasty, antihypertensive treatment was discontinued after the procedure but was subsequently resumed if hypertension persisted. Secondary end points were the treatment score and the incidence of complications. Two patients in the control group and 6 in the angioplasty group suffered procedural complications (relative risk, 3.4; 95% confidence interval, 0.8 to 15.1). Early termination was required for refractory hypertension in 7 patients in the control group. Antihypertensive treatment was resumed in 17 patients in the angioplasty group. Mean ambulatory blood pressure at termination did not differ between control (141+/-15/84+/-11 mm Hg) and angioplasty (140+/-15/81+/-9 mm Hg) groups. Angioplasty reduced by 60% the probability of having a treatment score of 2 or more at termination (relative risk, 0.4; 95% confidence interval, 0.2 to 0.7). There was 1 case of dissection with segmental renal infarction and 3 of restenosis in the angioplasty group. No patient suffered renal artery thrombosis. In unilateral atherosclerotic renal artery stenosis, angioplasty is a drug-sparing procedure that involves some morbidity. Previous uncontrolled and unblinded assessments of angioplasty overestimated its potential for lowering blood pressure.

摘要

相似文献

1
Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group.
Hypertension. 1998 Mar;31(3):823-9. doi: 10.1161/01.hyp.31.3.823.
2
The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group.球囊血管成形术治疗动脉粥样硬化性肾动脉狭窄所致高血压的效果。荷兰肾动脉狭窄干预协作研究组。
N Engl J Med. 2000 Apr 6;342(14):1007-14. doi: 10.1056/NEJM200004063421403.
3
Clinical and duplex ultrasound follow-up after balloon angioplasty for atherosclerotic renal artery stenosis.动脉粥样硬化性肾动脉狭窄球囊血管成形术后的临床及双功超声随访
Vasc Surg. 2001 Mar-Apr;35(2):85-93. doi: 10.1177/153857440103500201.
4
[The long-term results on arterial pressure and kidney function after the percutaneous transluminal dilatation of renal artery stenosis].经皮腔内肾动脉狭窄扩张术后动脉血压及肾功能的长期结果
Med Clin (Barc). 1997 Mar 15;108(10):366-72.
5
Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: midterm technical and clinical results.
AJR Am J Roentgenol. 1997 Jan;168(1):245-51. doi: 10.2214/ajr.168.1.8976953.
6
Current Status of Renal Artery Angioplasty and Stenting for Resistant Hypertension: A Case Series and Review of the Literature.肾动脉血管成形术和支架置入术治疗顽固性高血压的现状:病例系列及文献综述
Curr Hypertens Rev. 2017;13(2):93-103. doi: 10.2174/1573402113666170804153026.
7
Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.肾动脉支架置入术治疗未控制高血压患者的收缩压显著降低:HERCULES 试验结果。
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):343-50. doi: 10.1002/ccd.24449. Epub 2012 Jun 27.
8
Endovascular management of atherosclerotic renovascular disease: early results following primary intervention.动脉粥样硬化性肾血管疾病的血管内治疗:初次干预后的早期结果
J Vasc Surg. 2008 Sep;48(3):580-7; discussion 587-8. doi: 10.1016/j.jvs.2008.04.050.
9
Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention?哪些患有高血压和动脉粥样硬化性肾动脉狭窄的患者能从即刻干预中获益?
J Hum Hypertens. 2004 Feb;18(2):91-6. doi: 10.1038/sj.jhh.1001641.
10
Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series.经皮腔内血管成形术治疗肾血管性高血压的血压反应:已发表系列研究综述
BMJ. 1990 Mar 3;300(6724):569-72. doi: 10.1136/bmj.300.6724.569.

引用本文的文献

1
Combination of medical therapy and percutaneous transluminal renal angioplasty versus medical therapy alone for patients with atherosclerotic renal artery stenosis: systematic review and meta-analysis.药物治疗与经皮腔内肾血管成形术联合治疗与单纯药物治疗对动脉粥样硬化性肾动脉狭窄患者的疗效比较:系统评价与荟萃分析
Hypertens Res. 2025 Jun;48(6):1870-1879. doi: 10.1038/s41440-025-02166-3. Epub 2025 Mar 4.
2
[What is new in the management of peripheral arterial occlusive disease and diseases of the aorta? : Highlights of the ESC guidelines 2024].[外周动脉闭塞性疾病和主动脉疾病管理的新进展是什么?:2024年欧洲心脏病学会指南要点]
Herz. 2025 Feb;50(1):25-33. doi: 10.1007/s00059-024-05286-7. Epub 2024 Nov 26.
3
Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL Trial.
ASTRAL 试验中动脉粥样硬化性肾血管疾病的肾血管重建后的长期结果。
Circ Cardiovasc Interv. 2024 Sep;17(9):e013979. doi: 10.1161/CIRCINTERVENTIONS.123.013979. Epub 2024 Aug 15.
4
Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure.Pickering 综合征:被忽视的复发性心力衰竭肾血管性病因。
J Am Heart Assoc. 2023 Oct 3;12(19):e030474. doi: 10.1161/JAHA.123.030474. Epub 2023 Sep 26.
5
Bilateral renal artery stenosis impacts postoperative complications after major vascular surgery.双侧肾动脉狭窄会影响大血管手术后的术后并发症。
Surg Open Sci. 2023 Jun 12;14:17-21. doi: 10.1016/j.sopen.2023.06.001. eCollection 2023 Aug.
6
Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH).动脉粥样硬化性肾血管疾病:欧洲肾脏病最佳实践(ERBP)协会、欧洲高血压学会(ESH)高血压与肾脏工作组的临床实践文件
Nephrol Dial Transplant. 2023 Nov 30;38(12):2835-2850. doi: 10.1093/ndt/gfad095.
7
Unilateral renal artery stenosis causing hypertensive flash pulmonary oedema.单侧肾动脉狭窄导致高血压性闪发性肺水肿。
BMJ Case Rep. 2021 Sep 12;14(9):e244402. doi: 10.1136/bcr-2021-244402.
8
Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference.动脉粥样硬化性肾血管疾病:KDIGO(肾脏病:改善全球预后)争议会议。
Am J Kidney Dis. 2022 Feb;79(2):289-301. doi: 10.1053/j.ajkd.2021.06.025. Epub 2021 Aug 9.
9
Use of percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis: a systematic review and meta-analysis.经皮腔内肾血管成形术在动脉粥样硬化性肾动脉狭窄中的应用:一项系统评价和荟萃分析。
J Int Med Res. 2021 Jan;49(1):300060520983585. doi: 10.1177/0300060520983585.
10
[Treatment of renal artery stenosis in the year 2021].[2021年肾动脉狭窄的治疗]
Internist (Berl). 2021 Mar;62(3):252-262. doi: 10.1007/s00108-020-00935-5. Epub 2021 Jan 18.